SCHEMBL3012072

SCHEMBL3012072

CCOC(=O)c1c(CN(C)C)c2cc(-c3ccc(C(C)(C)C)cc3)ccc2n1-c1ccc(OC(C)C)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGES O14684 3/20 0.51
PPARG P37231 4/20 0.38
PPARA Q07869 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NR1H4 Q96RI1 1/20 0.37
THRB P10828 1/20 0.37
MAPK8 P45983 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 2/20 0.35
MAPT P10636 2/20 0.35
HDAC6 Q9UBN7 1/20 0.35
SIRT2 Q8IXJ6 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
SERPINE1 P05121 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL334000 0.91 PTGES (0.48) PTGESPPARGPPARASMN1; SMN2MEN1
SCHEMBL3002045 0.90 PTGES (0.59) PTGESPPARGPPARANR1H4
SCHEMBL4021254 0.87 PTGES (0.59) PTGESPPARGPPARASMN1; SMN2KMT2A
SCHEMBL4698609 0.86 PTGES (0.51) PTGESPPARGPPARASMN1; SMN2MEN1
SCHEMBL4698398 0.86 PTGES (0.55) PTGESPPARGPPARASMN1; SMN2MEN1
SCHEMBL1407310 0.85 PTGES (0.49) PTGESPPARGPPARASMN1; SMN2NR1H4
SCHEMBL3000522 0.85 PTGES (0.48) PTGESSMN1; SMN2MEN1KMT2AMAPK8
SCHEMBL333585 0.85 PTGES (0.52) PTGESPPARGPPARA
SCHEMBL4700726 0.84 PTGES (0.53) PTGESPPARGPPARASMN1; SMN2NR1H4
SCHEMBL334136 0.84 PTGES (0.53) PTGESPPARGPPARASMN1; SMN2NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100197687-A1 Indoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197687-A1 Indoles Useful in the Treatment of Inflammation IDO1, IDO2, TPH1 PTGES 33/4885PPARG 2505/4885PPARA 3519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.